Anna Szczepanska-Szerej
Overview
Explore the profile of Anna Szczepanska-Szerej including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szmygin M, Bielewicz J, Pyra K, Szczepanska-Szerej A, Rejdak K
Gastroenterol Rep (Oxf)
. 2021 May;
9(2):179-181.
PMID: 34026226
No abstract available.
2.
Marciniec M, Szczepanska-Szerej A, Papuc E, Rejdak K
Int J Neurosci
. 2020 Dec;
132(10):1026-1030.
PMID: 33295845
Aims: Cervical pain is one of the most common non-motor symptoms of cervical dystonia (CD) and affects from 54.6% to 88.9% of patients. To date, minority of studies investigated the...
3.
Sapko K, Jamroz-Wisniewska A, Marciniec M, Kulczynski M, Szczepanska-Szerej A, Rejdak K
Neurol Neurochir Pol
. 2020 Oct;
55(1):117.
PMID: 33026645
No abstract available.
4.
Marciniec M, Szczepanska-Szerej A, Rejdak K
Neurol Res
. 2020 Jul;
42(11):987-991.
PMID: 32693754
Objectives: Botulinum toxin (BoNT) is an effective first-line treatment for cervical dystonia (CD). Despite generally good therapeutic efficacy, approximately 20-40% of CD patients do not achieve acceptable relief of the...
5.
Bielewicz J, Kurzepa J, Kamieniak P, Daniluk B, Szczepanska-Szerej A, Rejdak K
Ann Agric Environ Med
. 2020 Jun;
27(2):290-294.
PMID: 32588608
Objective: The aim of this study is to evaluate neurological scales, as well as biochemical and radiological parameters measured on day 10 after ischemic stroke (IS), according to their value...
6.
Sapko K, Jamroz-Wisniewska A, Marciniec M, Kulczynski M, Szczepanska-Szerej A, Rejdak K
Neurol Neurochir Pol
. 2020 May;
54(3):252-258.
PMID: 32462652
Introduction: Multiple Sclerosis (MS) is a chronic, demyelinating disease of the central nervous system which affects mostly young people. Because it leads to disability and cognitive impairment, it is crucial...
7.
Sarzynska-Dlugosz I, Szczepanska-Szerej A, Druzdz A, Lukomski T, Ochudlo S, Fabian A, et al.
Neurol Neurochir Pol
. 2020 Jan;
54(1):90-99.
PMID: 31956971
AbobotulinumtoxinA (aboBoNT-A, Dysport®) is used in clinical practice as a well-tolerated and effective therapy for muscle spasticity. AboBoNT-A has been shown to reduce upper and lower limb spastic paresis in...
8.
Marciniec M, Sapko K, Kulczynski M, Popek-Marciniec S, Szczepanska-Szerej A, Rejdak K
Clin Neurol Neurosurg
. 2019 Oct;
187:105561.
PMID: 31634685
Cervical artery dissection (CAD) is a leading cause of ischaemic stroke (IS) in young and middle-aged adults. Despite well characterized clinical presentation, the diagnosis of CAD can be quite challenging...
9.
Marciniec M, Szczepanska-Szerej A, Kulczynski M, Sapko K, Popek-Marciniec S, Rejdak K
Rev Neurosci
. 2019 Mar;
30(7):771-779.
PMID: 30917105
Pain is the most common and disabling non-motor symptom in cervical dystonia (CD). Up to 88.9% of patients report pain at some point in the course of the disease. It...
10.
Bielewicz J, Szczepanska-Szerej A, Ogorek M, Dropko P, Wojtal K, Rejdak K
Prion
. 2018 Jan;
12(2):143-146.
PMID: 29380664
We reported the case of a patient with Wernicke-Korsakoff syndrome (WKs) as an early clinical manifestation of sporadic Creutzfeld-Jakob disease (sCJD). The 66-year-old female complained of dizziness and imbalance which...